Versant Venture Capital Vii, L's Net Worth
Versant Venture Capital Vii, L's net worth is estimated to be at least $16,740,000.00 as of 11/20/2024. CoreStreet's estimation of Versant Venture Capital Vii, L's net worth is based on their sale of stock and current holding of stock.
Versant Venture Capital Vii, L is Major Shareholder at Chinook Therapeutics Inc. They have executed at least 2 trades of stock as per SEC Form 4 filings. Their most recent trade was for 600,000 units of KDNY stock on 01/03/2022. Their biggest sale was on 01/03/2022 when they sold 600,000 units of Chinook Therapeutics Inc stock for $9,600,000.00. They typically trade 1 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $16,740,000.00
Most recent insider trade:
- Jan. 3, 2022
Versant Venture Capital Vii, L's Insider Trading History
| Chinook Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 3, 2022 | Major Shareholder | 600,000 | $16.00 | Sell | $9,600,000.00 |
Aug. 27, 2021 | Major Shareholder | 510,000 | $14.00 | Sell | $7,140,000.00 |